85 related articles for article (PubMed ID: 29518677)
1. Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Baumgartner A; Tausch C; Hosch S; Papassotiropoulos B; Varga Z; Rageth C; Baege A
Breast; 2018 Jun; 39():19-23. PubMed ID: 29518677
[TBL] [Abstract][Full Text] [Related]
2. Outcome after neoadjuvant chemotherapy in Asian breast cancer patients.
Lim LY; Miao H; Lim JS; Lee SC; Bhoo-Pathy N; Yip CH; Taib NA; Chan P; Tan EY; Lim SH; Lim GH; Woo E; Tan YS; Lee JA; Wong M; Tan PH; Ong KW; Wong FY; Yap YS; Hartman M
Cancer Med; 2017 Jan; 6(1):173-185. PubMed ID: 28000426
[TBL] [Abstract][Full Text] [Related]
3. Prediction of complete response after neoadjuvant chemotherapy for invasive breast cancers: The utility of shear wave elastography and superb microvascular imaging in pretreatment breast ultrasound.
Lee EJ; Chang YW
Eur J Radiol; 2024 Jun; 175():111432. PubMed ID: 38554672
[TBL] [Abstract][Full Text] [Related]
4. Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
van Loevezijn AA; van der Noordaa MEM; van Werkhoven ED; Loo CE; Winter-Warnars GAO; Wiersma T; van de Vijver KK; Groen EJ; Blanken-Peeters CFJM; Zonneveld BJGL; Sonke GS; van Duijnhoven FH; Vrancken Peeters MTFD
Ann Surg Oncol; 2021 Jun; 28(6):3243-3253. PubMed ID: 33263830
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography.
Conz L; Jales RM; Dória MT; Melloni I; Cres Lyrio CA; Menossi C; Derchain S; Sarian LO
PLoS One; 2024; 19(6):e0302527. PubMed ID: 38833499
[TBL] [Abstract][Full Text] [Related]
6. Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
Deng B; Muldoon A; Cormier J; Mercaldo ND; Niehoff E; Moffett N; Saksena MA; Isakoff SJ; Carp SA
J Biomed Opt; 2024 Jun; 29(6):066001. PubMed ID: 38737790
[TBL] [Abstract][Full Text] [Related]
7. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
Shang Y; Wang X; Liu Y; Cheng W; Duan Y; Fang Z; Liu J; Kong F; Wang T; Yu T; Hu A; Zhang J; Zhang H; Li M; Rong Z; Li Y; Shakila SS; Li X; Feng J; Ma F; Guo B
Breast Cancer; 2024 Apr; ():. PubMed ID: 38643430
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of background parenchymal enhancement on breast magnetic resonance imaging for pathological tumor response to neoadjuvant chemotherapy in breast cancers: a systematic review.
Li X; Yan F
Cancer Imaging; 2024 Mar; 24(1):35. PubMed ID: 38462607
[TBL] [Abstract][Full Text] [Related]
9. Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy.
Lin D; Sturgeon KM; Muscat JE; Zhou S; Hobkirk AL; O'Brien KM; Sandler DP; Thompson CL
Breast Cancer; 2024 May; 31(3):519-528. PubMed ID: 38564089
[TBL] [Abstract][Full Text] [Related]
10. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?
Cai L; Sidey-Gibbons C; Nees J; Riedel F; Schäfgen B; Togawa R; Killinger K; Heil J; Pfob A; Golatta M
Eur Radiol; 2024 Apr; 34(4):2560-2573. PubMed ID: 37707548
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced pathologic response in breast angiosarcoma.
Chang HY; Dermawan JK; Kuba MG; Crago AM; Singer S; Tap W; Chi P; D'Angelo S; Rosenbaum E; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23240. PubMed ID: 38722225
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-based radiomics for early predicting response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review with meta-analysis.
Li Z; Liu X; Gao Y; Lu X; Lei J
Radiol Med; 2024 Jun; 129(6):934-944. PubMed ID: 38630147
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative MRI in evaluating pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer: a study focused on influencing factors of baseline clinical-pathological and imaging features.
Hu Q; Hu Y; Ai H; Xia L; Liu R; Ai T
Front Oncol; 2024; 14():1366613. PubMed ID: 38826784
[TBL] [Abstract][Full Text] [Related]
14. Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study.
Schettini F; Saracchini S; Bassini A; Marus W; Corsetti S; Specogna I; Bertola M; Micheli E; Wirtz RM; Laible M; Şahin U; Strina C; Milani M; Aguggini S; Tancredi R; Fiorio E; Sulfaro S; Generali D
Breast; 2024 May; 76():103753. PubMed ID: 38815444
[TBL] [Abstract][Full Text] [Related]
15. New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort.
Hu Y; Mao L; Wang M; Li Z; Li M; Wang C; Ji L; Zeng H; Zhang X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7285-7297. PubMed ID: 36917189
[TBL] [Abstract][Full Text] [Related]
16. Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
von Waldenfels G; Loibl S; Furlanetto J; Machleidt A; Lederer B; Denkert C; Hanusch C; Kümmel S; von Minckwitz G; Schneeweiss A; Untch M; Rhiem K; Fasching PA; Blohmer JU
Oncotarget; 2018 Mar; 9(20):15168-15179. PubMed ID: 29632634
[TBL] [Abstract][Full Text] [Related]
17. High linoleic acid levels in red blood cells predict a poor response to neoadjuvant chemotherapy in human epidermal growth factor receptor type 2-positive breast cancer patients.
Valenzuela R; Walbaum B; Farias C; Acevedo F; Vargas C; Bennett JT; Bravo ML; Pinto MP; Medina L; Merino T; Ibañez C; Parada A; Sanchez C
Nutrition; 2024 May; 121():112357. PubMed ID: 38430738
[TBL] [Abstract][Full Text] [Related]
18. Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis.
Zhao F; Huo X; Wang M; Liu Z; Zhao Y; Ren D; Xie Q; Liu Z; Li Z; Du F; Shen G; Zhao J
Front Oncol; 2021; 11():731148. PubMed ID: 34778044
[TBL] [Abstract][Full Text] [Related]
19. Transforming breast cancer care: harnessing the power of artificial intelligence and imaging for predicting pathological complete response. a narrative review.
Shaikh K; Mooghal M; Ameen A; Khan W; Zeeshan S; Vohra LM
J Pak Med Assoc; 2024 Apr; 74(4 (Supple-4)):S43-S48. PubMed ID: 38712408
[TBL] [Abstract][Full Text] [Related]
20. Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies.
Debets DO; de Graaf EL; Liefaard MC; Sonke GS; Lips EH; Ressa A; Altelaar M
iScience; 2024 Jun; 27(6):109858. PubMed ID: 38784015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
